Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial-Reference-Cited by-同舟云学术

Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial

Published:2020-10-28 Issue:12 Volume:111 Page:4540-4547
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci.

Author:

Fukano Reiji¹^ORCID,Mori Tetsuya²,Sekimizu Masahiro³,Choi Ilseung⁴,Kada Akiko⁵,Saito Akiko Moriya⁵,Asada Ryuta⁶,Takeuchi Kengo⁷⁸⁹^ORCID,Terauchi Takashi¹⁰,Tateishi Ukihide¹¹,Horibe Keizo³⁵,Nagai Hirokazu⁵¹²

Affiliation:

1. Department of Pediatrics National Hospital Organization Kyushu Cancer Center Fukuoka Japan

2. Department of Pediatrics St. Marianna University School of Medicine Hospital Kanagawa Japan

3. Department of Pediatrics National Hospital Organization Nagoya Medical Center Nagoya Japan

4. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

5. Clinical Research Center National Hospital Organization Nagoya Medical Center Nagoya Japan

6. Innovative and Clinical Research Promotion Center Gifu University Hospital Gifu Japan

7. Division of Pathology Cancer Institute Japanese Foundation for Cancer Research Tokyo Japan

8. Pathology Project for Molecular Targets Cancer Institute Japanese Foundation for Cancer Research Tokyo Japan

9. Department of Pathology Cancer Institute Hospital Japanese Foundation for Cancer Research Tokyo Japan

10. Department of Nuclear Medicine Cancer Institute Hospital Japanese Foundation for Cancer Research Tokyo Japan

11. Department of Diagnostic Radiology and Nuclear Medicine Tokyo Medical and Dental University Tokyo Japan

12. Department of Hematology National Hospital Organization Nagoya Medical Center Nagoya Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14671

Reference31 articles.

1. Anaplastic large cell lymphoma in paediatric and young adult patients

2. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

3. CD301 anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features;Stein H;Blood,2000

4. Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia;npj Precision Oncology;2024-09-10

2. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

3. Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry;Blood Advances;2024-07-10

4. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

5. Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line;Human Cell;2024-05-16